Copyright Reports & Markets. All rights reserved.

Global and Japan Metabolomics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Metabolomics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Introduction
    • 1.2.3 Separation Techniques
    • 1.2.4 Detection Techniques
  • 1.3 Market by Application
    • 1.3.1 Global Metabolomics Market Share by Application: 2020 VS 2026
    • 1.3.2 Introduction
    • 1.3.3 Drug Assessment
    • 1.3.4 Biomarker Discovery
    • 1.3.5 Nutrigenomics
    • 1.3.6 Clinical toxicology
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Metabolomics Market Perspective (2015-2026)
  • 2.2 Global Metabolomics Growth Trends by Regions
    • 2.2.1 Metabolomics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Metabolomics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Metabolomics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Metabolomics Players by Market Size
    • 3.1.1 Global Top Metabolomics Players by Revenue (2015-2020)
    • 3.1.2 Global Metabolomics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Metabolomics Revenue
  • 3.4 Global Metabolomics Market Concentration Ratio
    • 3.4.1 Global Metabolomics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Revenue in 2019
  • 3.5 Key Players Metabolomics Area Served
  • 3.6 Key Players Metabolomics Product Solution and Service
  • 3.7 Date of Enter into Metabolomics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolomics Breakdown Data by Type (2015-2026)

  • 4.1 Global Metabolomics Historic Market Size by Type (2015-2020)
  • 4.2 Global Metabolomics Forecasted Market Size by Type (2021-2026)

5 Metabolomics Breakdown Data by Application (2015-2026)

  • 5.1 Global Metabolomics Historic Market Size by Application (2015-2020)
  • 5.2 Global Metabolomics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Metabolomics Market Size (2015-2026)
  • 6.2 North America Metabolomics Market Size by Type (2015-2020)
  • 6.3 North America Metabolomics Market Size by Application (2015-2020)
  • 6.4 North America Metabolomics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Metabolomics Market Size (2015-2026)
  • 7.2 Europe Metabolomics Market Size by Type (2015-2020)
  • 7.3 Europe Metabolomics Market Size by Application (2015-2020)
  • 7.4 Europe Metabolomics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Metabolomics Market Size (2015-2026)
  • 8.2 China Metabolomics Market Size by Type (2015-2020)
  • 8.3 China Metabolomics Market Size by Application (2015-2020)
  • 8.4 China Metabolomics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Metabolomics Market Size (2015-2026)
  • 9.2 Japan Metabolomics Market Size by Type (2015-2020)
  • 9.3 Japan Metabolomics Market Size by Application (2015-2020)
  • 9.4 Japan Metabolomics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Metabolomics Market Size (2015-2026)
  • 10.2 Southeast Asia Metabolomics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Metabolomics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Metabolomics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific, Inc.
    • 11.1.1 Thermo Fisher Scientific, Inc. Company Details
    • 11.1.2 Thermo Fisher Scientific, Inc. Business Overview
    • 11.1.3 Thermo Fisher Scientific, Inc. Metabolomics Introduction
    • 11.1.4 Thermo Fisher Scientific, Inc. Revenue in Metabolomics Business (2015-2020))
    • 11.1.5 Thermo Fisher Scientific, Inc. Recent Development
  • 11.2 Agilent Technologies, Inc.
    • 11.2.1 Agilent Technologies, Inc. Company Details
    • 11.2.2 Agilent Technologies, Inc. Business Overview
    • 11.2.3 Agilent Technologies, Inc. Metabolomics Introduction
    • 11.2.4 Agilent Technologies, Inc. Revenue in Metabolomics Business (2015-2020)
    • 11.2.5 Agilent Technologies, Inc. Recent Development
  • 11.3 Biocrates Life Sciences AG
    • 11.3.1 Biocrates Life Sciences AG Company Details
    • 11.3.2 Biocrates Life Sciences AG Business Overview
    • 11.3.3 Biocrates Life Sciences AG Metabolomics Introduction
    • 11.3.4 Biocrates Life Sciences AG Revenue in Metabolomics Business (2015-2020)
    • 11.3.5 Biocrates Life Sciences AG Recent Development
  • 11.4 Shimadzu Corporation
    • 11.4.1 Shimadzu Corporation Company Details
    • 11.4.2 Shimadzu Corporation Business Overview
    • 11.4.3 Shimadzu Corporation Metabolomics Introduction
    • 11.4.4 Shimadzu Corporation Revenue in Metabolomics Business (2015-2020)
    • 11.4.5 Shimadzu Corporation Recent Development
  • 11.5 Waters Corporation
    • 11.5.1 Waters Corporation Company Details
    • 11.5.2 Waters Corporation Business Overview
    • 11.5.3 Waters Corporation Metabolomics Introduction
    • 11.5.4 Waters Corporation Revenue in Metabolomics Business (2015-2020)
    • 11.5.5 Waters Corporation Recent Development
  • 11.6 Human Metabolome Technologies, Inc.
    • 11.6.1 Human Metabolome Technologies, Inc. Company Details
    • 11.6.2 Human Metabolome Technologies, Inc. Business Overview
    • 11.6.3 Human Metabolome Technologies, Inc. Metabolomics Introduction
    • 11.6.4 Human Metabolome Technologies, Inc. Revenue in Metabolomics Business (2015-2020)
    • 11.6.5 Human Metabolome Technologies, Inc. Recent Development
  • 11.7 LECO Corporation
    • 11.7.1 LECO Corporation Company Details
    • 11.7.2 LECO Corporation Business Overview
    • 11.7.3 LECO Corporation Metabolomics Introduction
    • 11.7.4 LECO Corporation Revenue in Metabolomics Business (2015-2020)
    • 11.7.5 LECO Corporation Recent Development
  • 11.8 Metabolon, Inc.
    • 11.8.1 Metabolon, Inc. Company Details
    • 11.8.2 Metabolon, Inc. Business Overview
    • 11.8.3 Metabolon, Inc. Metabolomics Introduction
    • 11.8.4 Metabolon, Inc. Revenue in Metabolomics Business (2015-2020)
    • 11.8.5 Metabolon, Inc. Recent Development
  • 11.9 Bio-Rad Laboratories, Inc.
    • 11.9.1 Bio-Rad Laboratories, Inc. Company Details
    • 11.9.2 Bio-Rad Laboratories, Inc. Business Overview
    • 11.9.3 Bio-Rad Laboratories, Inc. Metabolomics Introduction
    • 11.9.4 Bio-Rad Laboratories, Inc. Revenue in Metabolomics Business (2015-2020)
    • 11.9.5 Bio-Rad Laboratories, Inc. Recent Development
  • 11.10 Bruker Corporation
    • 11.10.1 Bruker Corporation Company Details
    • 11.10.2 Bruker Corporation Business Overview
    • 11.10.3 Bruker Corporation Metabolomics Introduction
    • 11.10.4 Bruker Corporation Revenue in Metabolomics Business (2015-2020)
    • 11.10.5 Bruker Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Metabolomics Scope and Market Size
    Metabolomics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabolomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Introduction
    Separation Techniques
    Detection Techniques

    Market segment by Application, split into
    Introduction
    Drug Assessment
    Biomarker Discovery
    Nutrigenomics
    Clinical toxicology
    Others

    Based on regional and country-level analysis, the Metabolomics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Metabolomics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Thermo Fisher Scientific, Inc.
    Agilent Technologies, Inc.
    Biocrates Life Sciences AG
    Shimadzu Corporation
    Waters Corporation
    Human Metabolome Technologies, Inc.
    LECO Corporation
    Metabolon, Inc.
    Bio-Rad Laboratories, Inc.
    Bruker Corporation

    Buy now